FDA Adverse Event Malfunction Summary report: N

ACCESS HYPERSENSITIVE HTSH

MDR report key: 3898475 · Received June 26, 2014

Report

Report Number
8020879-2014-00005
Event Type
Malfunction
Date Received
June 26, 2014
Date of Event
May 28, 2014
Report Date
June 2, 2014
Manufacturer
BECKMAN COULTER
Product Code
JLW
PMA / PMN Number
K042281
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

BECKMAN COULTER (BEC) FIELD SERVICE WAS NOT DISPATCHED; THE CUSTOMER HAS A CONTRACT FOR FIELD SERVICE WITH A DIFFERENT COMPANY. ASSOCIATED MDR: 8020879-2014-00006.

Description of Event or Problem · 1

THE CUSTOMER REPORTED ERRONEOUS THYROID-STIMULATING HORMONE (HTSH) RESULTS WERE GENERATED FOR ONE PATIENT ON TWO INSTRUMENTS. THIS MDR REPORTS THE RESULTS GENERATED ON A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM; PLEASE SEE MDR 8020879-2014-00006 FOR THE RESULTS GENERATED ON A UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM. THE PATIENT SAMPLE WAS INITIALLY ANALYZED ON A UNICEL DXI 600 ACCESS IMMUNOASSAY SYSTEM AND THE HTSH RESULT WAS BELOW THE LABORATORY'S NORMAL REFERENCE RANGE. THE CUSTOMER RETESTED THE SAMPLE SEVERAL TIMES ON THE SAME INSTRUMENT AND ON A UNICEL DXI 800 ACCESS IMMUNOASSAY SYSTEM IN THE SAME LABORATORY; HTSH RESULTS WERE BELOW, WITHIN, AND ABOVE THE REFERENCE RANGE. A RERUN RESULT WITHIN THE NORMAL REFERENCE RANGE WAS REPORTED OUT OF THE LABORATORY. THERE WAS NO CHANGE TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT. A REVIEW OF QUALITY CONTROL (QC) DATA SHOWS THAT HTSH QC RESULTS WERE WITHIN THE LABORATORY'S ESTABLISHED RANGE ON THE DATE OF THE EVENT. THE CUSTOMER DID NOT REPORT ANY SAMPLE QUALITY ISSUES. THE INSTRUMENT HAD BEEN CALIBRATED WITH ACCESS HTSH CALIBRATOR LOT 333848.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
373668 ACCESS HYPERSENSITIVE HTSH RADIOIMMUNOASSAY, THYROID-STIMULATING HORMONE JLW BECKMAN COULTER NA 423688

Patients

Seq Age Sex Outcome Treatment
1 91 YR